Mesenchymal stem cells might be the answer to spinal cord injury
In India, 20,000 new cases of spinal cord injury are added to the list every year, as compared to 11,000 in US and 700 in UK. Stempeutics Research has done a pilot study on the application of mesenchymal stem cells in spinal cord injury. Patients with fresh injuries have responded well to this therapy. Although many cell types contribute to organ repair in spinal cord injury, bone marrow mesenchymal stem cells have the greatest potential for repairing the spinal cord injury. Stempeutics has collaborated with Manipal Hospital for these pilot studies.